Supplementary Material - Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic Hand Eczema: results of the phase 3 open-label extension DELTA 3 trial following the DELTA 1 and 2 trials
收藏Mendeley Data2026-04-09 收录
下载链接：
https://data.mendeley.com/datasets/rjrvyss2vg/2
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary Information to accompany and support the manuscript: Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic Hand Eczema: results of the phase 3 open-label extension DELTA 3 trial following the DELTA 1 and 2 trials
